Related Experiment Video
Updated: May 1, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension
Roberto Pontremoli1, Giovanna Leoncini, Francesca Viazzi
1Department of Internal Medicine, University of Genoa, Genoa, Italy. rpontrem@medicina.unige.it
Insights
Blood pressure (BP) alone is a poor predictor of cardiovascular risk. A comprehensive assessment including target organ damage, identified through methods like microalbuminuria screening, offers a more accurate risk evaluation for hypertensive patients.
Area of Science:
- Cardiology
- Nephrology
- Public Health
Background:
- Blood pressure (BP) levels alone are insufficient for accurately assessing individual cardiovascular risk.
- The global cardiovascular profile, incorporating target organ damage, is a superior predictor of future adverse events.
- Diagnostic techniques significantly influence the detection rate of target organ damage and patient risk stratification.
Purpose of the Study:
- To evaluate the effectiveness of microalbuminuria screening in identifying high-risk hypertensive patients.
- To optimize the cost-effectiveness of diagnostic workups in hypertension management.
- To emphasize the importance of a comprehensive cardiovascular risk assessment beyond simple BP measurements.
Main Methods:
- Analysis of diagnostic techniques for target organ damage in hypertensive patients.
- Evaluation of the prevalence of high-risk patients identified through routine microalbuminuria testing.
- Assessment of the cost-effectiveness of diagnostic strategies in hypertension.
Main Results:
- Routine microalbuminuria screening detects a significantly higher percentage of high-risk hypertensive patients.
- Comprehensive cardiovascular profiling, including target organ damage, improves risk prediction compared to BP levels alone.
- Optimizing diagnostic workups enhances cost-effectiveness in managing hypertension.
Conclusions:
- Microalbuminuria screening is a valuable tool for identifying high-risk individuals within the hypertensive population.
- A holistic approach to cardiovascular risk assessment, beyond BP, is crucial for effective treatment and goal setting.
- Balancing thorough diagnostics with cost-effectiveness is essential in public health strategies for hypertension.
Abstract:
BP levels per se may be an unreliable indicator of risk in the individual patient. In fact, the global cardiovascular profile, including the presence and degree of target organ damage, is a better predictor of future events and, therefore, should be used to choose both treatment and BP goals. However, the prevalence of target organ damage and therefore the percentage of patients who are at risk very much depends on the diagnostic techniques used. However, as a result of the high prevalence of hypertension and its financial impact on public health systems, limiting unnecessary and extensive diagnostic tests also should be a priority. The routine search for microalbuminuria may lead to the detection of a significantly greater percentage of patients who are at high risk while contributing the optimization of the cost-effectiveness of diagnostic workup in hypertensive patients.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

